A comprehensive review of upper reference limits reported for (high-)sensitivity cardiac troponin assays: The challenges that lie ahead

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 5, 2012, Pages 791-806

  Cardinaels, Eline P M ^a   Mingels, Alma M A ^a   Jacobs, Leo H J ^a   Meex, Steven J R ^a   Bekers, Otto ^a   Van Dieijen Visser, Marja P ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute coronary syndrome; Analytical performance; Cardiac troponin; Immunoassays; Reference population; Upper reference limit

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HETEROPHILE ANTIBODY; TROPONIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOGRAPHY; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONTROLLED STUDY; HEART RATE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; SENSITIVITY ANALYSIS; SEX DIFFERENCE; STRESS ECHOCARDIOGRAPHY; URINALYSIS;

CLINICAL CHEMISTRY TESTS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; REFERENCE VALUES; TROPONIN;

EID: 84867791276     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2011-0895     Document Type: Review

References (69)

1. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-21.
2. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
3. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
4. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007;115:e356-75.
5. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH, Cannon C P, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007;53:547-51.
6. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197-204.
7. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on the Standardization of Markers of Cardiac Damage (C-SMCD). Troponin assay analytical characteristics. Accessed 11 Jun. 2011. Available at: http://www.ifcc.org/PDF/ScientificActivities/IFCC-Troponin-Table-vDec-2010- FINAL-ng-L-28Jan11.pdf.
8. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-6.
9. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im) precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the defini-tion of myocardial infarction. Clin Chem 2010;56:941-3.
10. Morrow DA, Antman EM. Evaluation of high-sensitivity assays for cardiac troponin. Clin Chem 2009;55:5-8.
11. Panteghini M. A critical appraisal of experimental factors influ-encing the definition of the 99th percentile limit for cardiac tro-ponins. Clin Chem Lab Med 2009;47:1179-82.
12. Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chim Acta 2009;402:88-93.
13. De Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. J Am Med Assoc 2010;304:2503-12.
14. De Filippi CR, De Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. J Am Med Assoc 2010;304:2494-502.
15. Solberg HE. Establishment and use of reference values. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. Philadelphia: Elsevier Saunders, 2006:425-48.
16. Pulkki K, Suvisaari J, Collinson P, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, et al. A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study. Clin Chem Lab Med 2009;47:227-34.
17. Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, et al. Prognostic value of very low plasma concentrations of tro-ponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-9.
18. Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:1086-90.
19. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-61.
20. Beyrau R, Braun S, Dolci A, Freidank H, Giannitsis E, Handy B, et al. Multicentre evaluation of a high sensitive Elecsys troponin T assay [Abstract]. Clin Chem 2009;55:A70.
21. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011;412:748-54.
22. Aw TC, Pua SK, Yew L, Lim WR, Tan SP. Performance of a new rapid automated high-sensitive troponin T (hsTnT) immunoassay [Abstract]. Clin Chem 2010;56:C88.
23. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, Van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-8.
24. Koerbin G, Tate JR, Hickman PE. Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy population. Ann Clin Biochem 2010;47:524-8.
25. Collinson P, Heung Y, Gaze D, Boa F, Senior R. The assay performance and 99th percentile reference limit for cardiac troponin T using a new high sensitivity assay in a fully characterised reference population [Abstract]. Clin Chem 2010;56:C50.
26. Chenevier-Gobeaux C, Meune C, Blanc MC, Cynober L, Jaffray P, Lefevre G. Analytical evaluation of a high-sensitivity troponin T assay and its clinical assessment in acute coronary syndrome. Ann Clin Biochem 2011;48:542-8.
27. Vasatova M, Pudil R, Tichy M, Buchler T, Horacek JM, Haman L, et al. High-sensitivity troponin T as a marker of myocardial injury after radiofrequency catheter ablation. Ann Clin Biochem 2011;48:38-40.
28. La'ulu SL, Roberts WL. Performance characteristics of five cardiac Troponin I assays. Clin Chim Acta 2010;411:1095-101.
29. Collinson PO, Clifford-Mobley O, Gaze D, Boa F, Senior R. Assay imprecision and 99th-percentile reference value of a high-sensitivity cardiac troponin I assay. Clin Chem 2009;55:1433-4.
30. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
31. Sthaneshwar P, Jamaluddin FA, Fan YS. Reference value for cardiac troponin I in a multi-ethnic group. Pathology 2010;42:454-6.
32. Clerico A, Fortunato A, Ripoli A, Prontera C, Zucchelli GC, Emdin M. Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations. Clin Chem Lab Med 2008;46:804-8.
33. Prontera C, Fortunato A, Storti S, Mercuri A, Boni C, Zucchelli GC, et al. Evaluation of analytical performance of Advia ® TnI ultra immunoassay and comparison with Access ® AccuTnITM method. Immuno-Anal Biol Spe 2008;23:311-8.
34. Venge P, James S, Jansson L, Lindahl B. Clinical performance of two highly sensitive cardiac troponin I assays. Clin Chem 2009;55:109-16.
35. Prontera C, Fortunato A, Storti S, Mercuri A, Longombardo G, Zucchelli GC, et al. Evaluation of analytical performance of the Siemens ADVIA TnI ultra immunoassay. Clin Chem 2007;53:1722-3.
36. Tate JR, Ferguson W, Bais R, Kostner K, Marwick T, Carter A. The determination of the 99th centile level for troponin assays in an Australian reference population. Ann Clin Biochem 2008;45:275-88.
37. Van De Kerkhof D, Peters B, Scharnhorst V. Performance of the Advia Centaur second-generation troponin assay TnI-Ultra compared with the first-generation cTnI assay. Ann Clin Biochem 2008;45:316-7.
38. Christenson RH, Cervelli DR, Bauer RS, Gordon M. Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentrations. Clin Biochem 2004;37:679-83.
39. Di Serio F, Amodio G, Varraso L, Campaniello M, Coluccia P, Trerotoli P, et al. Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation. Clin Chem Lab Med 2005;43:202-9.
40. Altinier S, Mion M, Cappelletti A, Zaninotto M, Plebani M. Rapid measurement of cardiac markers on Stratus CS. Clin Chem 2000;46:991-3.
41. Heeschen C, Goldmann BU, Langenbrink L, Matschuck G, Hamm CW. Evaluation of a rapid whole blood ELISA for quanti-fication of troponin I in patients with acute chest pain. Clin Chem 1999;45:1789-96.
42. Arrebola MM, Lillo JA, Diez De Los Rios MJ, Rodriguez M, Dayaldasani A, Yahyaoui R, et al. Analytical performance of a sensitive assay for cardiac troponin I with loci technology. Clin Biochem 2010;43:998-1002.
43. Apple FS, Murakami MM. Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd-generation assays. Clin Chem 2007;53:1558-60.
44. Saw S, Wang C, Sethi S. Meeting the challenge of the ESC/ACC definition of myocardial infarction of the new troponin I ES on the VITROS ® 5600 integrated system and VITROS ® ECi immu-nodiagnostic system [Abstract]. Clin Chem 2009;55:B51.
45. Zaninotto M, Mion MM, Novello E, Moretti M, Delprete E, Rocchi MB, et al. Precision performance at low levels and 99th percentile concentration of the Access AccuTnl assay on two different platforms. Clin Chem Lab Med 2009;47:367-71.
46. James S, Flodin M, Johnston N, Lindahl B, Venge P. The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin Chem 2006;52:832-7.
47. Venge P, Johnston N, Lagerqvist B, Wallentin L, Lindahl B. Clinical and analytical performance of the liaison cardiac tro-ponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy. Clin Chem 2003;49:880-6.
48. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl B. Value of cardiac troponin I cut-off concentrations below the 99th percentile for clinical decision-making. Clin Chem 2009;55:85-92.
49. Apple FS, Murakami MM. Serum 99th percentile reference cut-offs for seven cardiac troponin assays. Clin Chem 2004;50:1477-9.
50. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology Consensus Recommendations. Clin Chem 2003;49:1331-6.
51. Eriksson S, Ilva T, Becker C, Lund J, Porela P, Pulkki K, et al. Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies. Clin Chem 2005;51:848-55.
52. Beyne P, Bouvier E, Werner P, Bourgoin P, Logeart D, Alliot L, et al. Emergency department triage of patients with acute chest pain: definition of cardiac troponin I decisional value to manage patients without electrocardiographic evidence of ischemia. Clin Chem Lab Med 2004;42:556-9.
53. Venge P, Lindahl B, Wallentin L. New generation cardiac tro-ponin I assay for the access immunoassay system. Clin Chem 2001;47:959-61.
54. Le Moal E, Giuliani I, Bertinchant JP, Polge A, Larue C, Villard-Saussine S. Earlier detection of myocardial infarction by an improved cardiac TnI assay. Clin Biochem 2007;40:1065-73.
55. Uettwiller-Geiger D, Wu AH, Apple FS, Jevans AW, Venge P, Olson MD, et al. Multicenter evaluation of an automated assay for troponin I. Clin Chem 2002;48:869-76.
56. Song S, Suh B, Lee SG, Kim JH, Kwon OH. Comparison of 10 % coefficient of variation and 99th percentile cut-off of troponin I in serum and heparinized plasma using Access 2 and DxI 800. Clin Chim Acta 2009;399:117-8.
57. Dupuy AM, Bouvier S, Bargnoux AS, Badiou S, Cristol JP. Clinical efficacy of two cardiac troponin I assays. Clin Chem Lab Med 2009;47:1013-5.
58. Lam Q, Black M, Youdell O, Spilsbury H, Schneider HG. Performance evaluation and subsequent clinical experience with the Abbott Automated Architect STAT Troponin-I assay. Clin Chem 2006;52:298-300.
59. Hubl W, Demant T, Gladrow E. Evaluation of the ARCHITECT STAT troponin-I assay. Clin Lab 2005;51:251-5.
60. Tovey JA, Brain A, Penney MD. Calculation of the 99th percen-tile upper reference limit and clinical decision concentration of the Abbott STAT TnI assay. Ann Clin Biochem 2010;47:576-7.
61. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-65.
62. Van De Kerkhof D, Peters B, Scharnhorst V. Troponin I concentrations in heparinized plasma and serum differ when measured with the Advia Centaur TnI-Ultra assay. Scand J Clin Lab Invest 2008:1-3.
63. Reiter M, Twerenbold R, Reichlin T, Haaf P, Peter F, Meissner J, et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011;32:1379-88.
64. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011;123:e18-209.
65. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
66. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short-and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009;55:52-8.
67. Petersen PH, Fraser CG, Sandberg S, Goldschmidt H. The index of individuality is often a misinterpreted quantity characteristic. Clin Chem Lab Med 1999;37:655-61.
68. Harris EK. Effects of intra-and interindividual variation on the appropriate use of normal ranges. Clin Chem 1974;20:1535-42.
69. Ceriotti F. Common reference intervals: the IFCC position. Clin Biochem 2009;42:297.